中国平安(02318.HK):寿险改革奠定未来十年发展基础
中国平安(02318.HK)首席保险业务执行官陆敏表示,内地推行寿险改革,发布《个险寿险业务人员基本管理办法》,料将奠定未来十年行业发展基础。
他表示,平安寿险2004年起从投连险产品转向保障型产品,并退出低价值的银保渠道,将保险代理人队伍从32万缩减到20万,经过多年发展,传统代理人模式已不能持续,去年下半年再推行业改革,涉及增长模式、营销体制、产品策略及渠道发展转型,未来将专注机构重新分类、外勤代理人分层以及加大对代理人队伍的长期投入。
陆敏透露,今年上半年平安寿险完成169万件赔付,与去年同期比较30分钟闪赔案件量比例从47%升至50%,办理时效最快仅1分钟。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.